Zealand Pharma A/S
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
26.03%
Market Cap
2.68 Bil.
P/E Ratio
5.09
Dividend Yield
0.00 %
Earnings per Share
12.29 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 37.97 G | 0 Units |
| PRICE DETERMINATION TIME | 06/23/2026 / 09:57:25 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 39.47 | 37.34 |
| PREV. DAY'S PRICE | 37.74 | (06/22) |
| CHANGE DAY BEFORE | +0.23 | 0.61 % |
| 52 WEEK HIGH / LOW | 73.9 (11/20) | 31.24 (03/09) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 1.04 | 2.72 | 12.29 | -2.18 | -1.67 |
| DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | 0.00 % | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | 36.25 | 13.80 | 5.09 | - | - |
| PRICE - BOOK RATIO | - | - | 2.22 | 5.87 | 13.68 |
| PRICE - SALES RATIO | - | - | 3.62 | 758.22 | 61.61 |
| PRICE - CASH FLOW RATIO | - | - | 5.11 | - | - |
Master Data
| WKN | A0YJW7 |
| ISIN | DK0060257814 |
| SYMBOL | 22Z |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Zealand Pharma |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Danish Krone |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 70.71 Mil. |
| MARKET CAPITALISATION | 2.68 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 0.53 % | -10.53 % | 3.60 % | -39.36 % | -26.03 % | 4.26 % | 54.85 % | -40.78 % |
| HIGH | 39.61 | 44.64 | 49.25 | 66.10 | 73.90 | 130.30 | 130.30 | 63.86 |
| LOW | 36.62 | 31.98 | 31.98 | 31.24 | 31.24 | 28.48 | 9.43 | 31.24 |
Dividend
per share
Zealand Pharma does not deliver dividend information
Company profile
Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on April 1, 1997 and is headquartered in Soborg, Denmark.
Structured products for Zealand Pharma A/S
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.